BridgeBio Oncology Therapeutics (BBOT) Technical Analysis

As of 2026-10-26, BBOT last traded at 2.64 USD (-0.75% on the day) and is in a range on the daily timeframe — insufficient history for 200-DMA. Nearest levels: no clear near support below, 4.15 USD resistance above. 14-day RSI is 18.1 (oversold).

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

Is BBOT in an uptrend or downtrend?

BridgeBio Oncology Therapeutics is in a range — insufficient history for 200-DMA.

Last close2.64 USD (-0.75%)
20-day average3.22 USD
50-day average5.507 USD
200-day averagen/a

Key support and resistance levels for BBOT

Derived from swing pivots over the last 69 sessions:

LevelTypeStrengthTouches
4.15 USDResistanceMinor1
9.36 USDResistanceMinor1
9.45 USDResistanceMinor1

No clearly-defined swing levels in the current range.

BBOT 52-week range, momentum and volatility

52-week high9.72 USD (72.8% below)
52-week low2.6 USD (1.5% above)
14-day RSI18.1 (Oversold)
14-day ATR0.192 USD (7.27% of price, High volatility)

Related research pages

More on BBOT

Frequently asked questions

Is BridgeBio Oncology Therapeutics (BBOT) in an uptrend or downtrend?

As of 2026-10-26, BBOT is in a range on the daily timeframe — insufficient history for 200-DMA. Last close 2.64 USD vs 50-day average 5.507 USD and 200-day average n/a.

What are the key support and resistance levels for BBOT?

No clear support below price in range. Nearest resistance is around 4.15 USD (minor). Levels are derived from swing pivots over the last ~200 sessions.

What is BBOT's 52-week high and low?

Over the last 52 weeks, BBOT traded between 2.6 USD and 9.72 USD. It is currently 72.8% below its 52-week high.

Is BBOT overbought or oversold?

The 14-day RSI is 18.1 — in oversold territory (<30). Momentum reads as oversold.

How volatile is BBOT?

Its 14-day Average True Range is 0.192 (7.27% of price) — high volatility relative to price.